Literature DB >> 19232759

An isolated right ventricular hypertrabeculation and dyskinesia in an elderly man: a possible diagnosis of isolated right ventricular noncompaction?

Ze-Zhou Song.   

Abstract

A 69-year-old man admitted with mild chest distress and palpitation associated with activity. He underwent an initial 2DE that did not confirm HVM/NVM and 3DE that strengthened the diagnosis of HVM/NVM. The limitations of 2DE may lead to misinterpretation of prominent trabeculations as "false tendons," and may also lead to underestimation of the severity of HVM/NVM. In contrast to 2DE, 3DE provides for pyramid-shaped datasets that encompass the entire right ventricular. Specifically, right ventricular can be sectioned in userselected planes and an unlimited number and angles of such planes can be used. Intracavitary echodensities that are suspicious for trabeculations can be tracked in multiple directions from base to apex. The present case should be regarded as isolated right ventricular HVM/NVM because there were no any factors that could explain the arrest of the development of the myocardial structure. In addition, the prompt recognition of HVM/NVM could suggest the high risk of arrhythmogenesis in patients with HVM/NVM.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19232759     DOI: 10.1016/j.ijcard.2009.01.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Right ventricular hypertrabeculation due to right heart failure after left ventricular assist device implantation.

Authors:  Christina Maria Steger; Susanne Reinold
Journal:  BMJ Case Rep       Date:  2012-08-02

2.  Sudden cardiac death in isolated right ventricular hypertrabeculation/noncompaction cardiomyopathy.

Authors:  Soad Bekheit; Boutros Karam; Farshid Daneshvar; Julie Zaidan; Rabih Tabet; Jonathan Spagnola; James Lafferty
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-12       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.